Atlas FDA

AFX Endovascular AAA System

FDA premarket approval P040002/S066 · decided 2020-08-05

Approval details

PMA number
P040002
Supplement
S066
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
AFX Endovascular AAA System
Generic name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Applicant
Endologix, LLC
Date received
2020-07-06
Decision date
2020-08-05
Days to decision
30 days
Decision code
OK30
Product code
MIH
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Manufacturing process changes related to the AFX2 implant loading procedure into the delivery system.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.